Articles on this Page
- 11/02/18--04:18: _Sprint legend Usain...
- 11/02/18--04:04: _Aleafia Launches Gl...
- 11/02/18--04:33: _Sport24.co.za | Ste...
- 11/02/18--04:27: _Traveller24.com | U...
- 11/02/18--04:38: _Australia, South Af...
- 11/02/18--04:50: _'New artificial int...
- 11/02/18--04:50: _Woman, 40, with a h...
- 11/01/18--21:53: _Australia: Soft ret...
- 11/01/18--22:25: _Letter 79: Our Netw...
- 11/01/18--22:19: _Australia: Housing ...
- 11/01/18--22:54: _Dog's day: Player's...
- 11/01/18--22:53: _RBA to stick to pos...
- 11/01/18--23:02: _Vietnam to ratify P...
- 11/02/18--00:43: _Asia shares reap bi...
- 11/02/18--01:26: _Althea granted cann...
- 11/02/18--06:19: _Self-styled preache...
- 11/02/18--07:02: _Cadre Technologies ...
- 11/02/18--10:02: _TransMachine Additi...
- 11/02/18--16:06: _Australia CFTC AUD ...
- 11/02/18--19:23: _Novichok victims Se...
- 11/02/18--04:18: Sprint legend Usain Bolt's Australian football dream collapses
- 11/02/18--04:33: Sport24.co.za | Steyn returns to scene of horror injury
- 11/02/18--04:50: 'New artificial intelligence bot can recognise galaxies'
- 11/01/18--21:53: Australia: Soft retail sales data - Westpac
- 11/01/18--22:19: Australia: Housing subdues inflation - Westpac
- 11/01/18--22:54: Dog's day: Player's pet quarantined on landing in Australia
- 11/01/18--22:53: RBA to stick to positive forecasts but risks are mounting - Westpac
- 11/01/18--23:02: Vietnam to ratify Pacific Rim trade pact
- 11/02/18--00:43: Asia shares reap big gains on news of Trump-Xi phone chat
- 11/02/18--01:26: Althea granted cannabis manufacture licence by Australian Government
- 11/02/18--10:02: TransMachine Additive Partners with The Barnes Group Advisors
- 11/02/18--16:06: Australia CFTC AUD NC net positions remains unchanged at $-70.4K
Sprint king Usain Bolt's attempt to become a professional footballer with Australia's Central Coast Mariners collapsed as his trial period was terminated after contract talks failed.
The eight-time Olympic champion had been trying out with the A-League side for an indefinite period since arriving in August, hoping to fulfil a childhood dream to become a football player. The 32-year-old superstar's quest garnered worldwide attention, which intensified when he scored two goals in a pre-season friendly.
But his abilities were questioned and the club reportedly offered him only a fraction of the Aus$3 million (USD 2.1 million) his management were said to be seeking, with outside sponsors needed to make the deal viable.
"As previously stated, the club and (Bolt's representative) Ricky Simms have been in conversations with external partners to find a commercial solution that suits all parties," the Mariners said in a statement. "Despite several promising potential partners, both Bolt and the Central Coast Mariners have amicably concluded that they will not be able to settle on a suitable deal in a timely manner."
The 100m world record holder, who retired from athletics last year and has previously tried out with clubs in Germany, South Africa and Norway, thanked the Mariners for the opportunity.
"I would like to thank the Central Coast Mariners owners, management, staff, players and fans for making me feel so welcome during my time there," said the Jamaican, who is reportedly in Melbourne and will head to Europe soon for a previously agreed commercial engagement. "I wish the club success for the season ahead."
Bolt recently turned down a trial-free contract from cashed-up Maltese champions Valletta to focus on trying to make the grade in Australia. That offer prompted the Mariners to table their own deal, but they didn't have the funds to make it work without outside help.
And coach Mike Mulvey made clear that Bolt, who favours playing up front, was unlikely to get much game time in the A-League even if he signed, with the team boosting an experienced front line. It includes Aston Villa marksmen and Scottish international Ross McCormack, who is on a season-long loan deal, and Tommy Oar, who has played 28 times for the Socceroos.
Bolt's abilities were also questioned by pundits and some players, including former Ireland striker Andy Keogh who last month said he had a "touch like a trampoline". Keogh, who used to play for Wolves and Cardiff, added: "He's shown a bit (of potential) but it's a little bit of a kick in the teeth to the professionals that are in the league."
The breakdown in his Australian quest coincided with Jamaican FA chief Michael Ricketts urging him to sign for a club in his homeland, dangling the prospect of being picked for the national team. "If he can make the transition from being a superstar on the track to being a good enough football player, then we will certainly call him up," he told ESPN.
Despite the failure to agree terms, Bolt's presence at the Mariners has garnered huge publicity for a club that finished bottom of the A-League last season. Owner Mike Charlesworth acknowledged Bolt's massive pulling power and said it had been a pleasure to have him on the Central Coast, around an hour's drive north of Sydney.
"This has been a mutually beneficial partnership that brought an increased level of excitement and attention to both the Mariners and the A-League," he said. "From day one, Usain dedicated himself to being part of the Mariners. He integrated very well into the team and made great strides as a footballer."
Central Coast Mariners
Fri, 2 Nov 2018-04:27pm
Friday, 2 November 2018 - 4:27pm
Hide lead image:
From Print Edition:
Highlights: Reported by DNA 37 minutes ago.
*Aleafia to Distribute Medical Cannabis, Provide Technical Expertise to CannaPacific*
TORONTO, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF: OTCQX: ALEAF, FRA: ARAH) (“*Aleafia*“) and CannaPacific Pty Ltd. (“*CannaPacific*”), together the (“*Parties*”), have signed a non-binding term sheet in which, upon completion of the transaction, Aleafia will acquire a 10 per cent equity stake in CannaPacific.
CannaPacific is a Licensed Australian Medical Cannabis company based in Newcastle and the Macleay Valley on the mid-north coast of NSW, Australia. As at the date of this Term Sheet, CannaPacific has been granted licences to cultivate, produce and research medical cannabis in Australia and has a 53,000 sq. ft. cannabis cultivation and plant research facility currently under construction.
Under the term sheet, Aleafia will provide CannaPacific with technical expertise in cannabis cultivation, processing, distribution and medical clinic operations.
· Launch of Aleafia’s global expansion with foothold in budding Australian medical cannabis market
· Future market access to Asia under free trade agreements between Australia and major countries
· International distribution of white label medical cannabis products
· Aleafia’s medical cannabis clinic and cultivation expertise to be deployed by CannaPacific
· Cannabis starter genetics to begin cultivation in CannaPacific cultivation facility
“This strategic investment in an emerging medical cannabis market marks Aleafia’s first step towards a broader global expansion,” said Aleafia Chairman Julian Fantino.
“We are extremely pleased to collaborate with CannaPacific, a company with the team in place to quickly capture market share in Australia,” said Aleafia CEO Geoffrey Benic. “This transaction, once completed, will place Aleafia at the epicentre of what we expect will be a major growth centre in the global medical cannabis market.”
“We are delighted to be partnering with Aleafia,” said CannaPacific CEO Joshua Dennis. “There are clear synergies between the two companies that will create long term, sustainable value in the Australasian market as we capitalize together on changes in the local regulatory environment. This will allow medical cannabis to play a vital role in lowering the disease burden on patients.”
The transaction is subject to the entering into of definitive agreements, due diligence and, if applicable, TSX Venture Exchange approvals.
*Aleafia Operational Update:*
· 160,000 sq. ft. Niagara greenhouse retrofitting on schedule and expected to be complete in late 2018
· Fully funded annual growing capacity of 98,000 kg of cannabis flower in 2019
· Signed supply agreement for CannTrust Holdings Inc. to purchase up to 15,000 kg of cannabis from Aleafia in 2019
· Reached milestone of 50,000 medical patients under the Canabo Medical Clinic network
· Local approval for a 30-acre, 60,000 kg secure outdoor grow expansion at our Port Perry cultivation facility
· Secured first medical cannabis sale in company’s history, only days after securing Sales Licence from Health Canada
· Added to Horizons Marijuana Life Sciences ETF, the largest cannabis ETF in the world
· Submitted application to list common shares on the NASDAQ stock exchange
Aleafia is a vertically integrated, national cannabis company with major medical clinic, cannabis cultivation and R&D operations. The company is a federally licensed producer and vendor of cannabis and will reach an annual production capacity of 98,000 kg of dried cannabis in 2019.
Aleafia operates 22 medical cannabis clinics staffed by physicians and nurse practitioners, with over 50,000 patients. The company is highly differentiated, maintaining the largest medical cannabis dataset in the world with significant intellectual property holdings and current R&D operations.
CannaPacific is a licensed Medical Cannabis Company based in Newcastle and the Macleay Valley on the mid-north coast of New South Wales (NSW), Australia.
CannaPacific has been granted licenses to cultivate and research medical cannabis in Australia and is in the process of constructing a 53,000 sq. ft. greenhouse cultivation and research facility. This project will position CannaPacific as a high-quality low-cost Australian producer. The CannaPacific Team comprises experts in the medical, clinical trials, plant Science, technology and pharmaceutical industries with vast experience and world class capability from the opiates and related industries.
For more information visit www.cannapacific.com.au.
*For Investor & Media Relations, please contact:*
Nicholas Bergamini, VP Public Affairs
*Neither Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.*
*FORWARD LOOKING INFORMATION*
This press release contains forward-looking statements and information that are based on the beliefs of management and reflect the Company's current expectations. When used in this press release, the words "estimate", "project", "belief", "anticipate", "intend", "expect", "plan", "predict", "may" or "should" and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. The forward-looking statements and information in this press release includes information relating to the implementation of Aleafia Health's business plan. Such statements and information reflect the current view of the Company with respect to risks and uncertainties that may cause actual results to differ materially from those contemplated in those forward-looking statements and information.
By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the following risks: risks associated with the implementation of Aleafia Health's business plan and matters relating thereto, risks associated with the cannabis industry, competition, regulatory change, the need for additional financing, reliance on key personnel, the potential for conflicts of interest among certain officers or directors, and the volatility of the Company's common share price and volume. Forward-looking statements are made based on management's beliefs, estimates and opinions on the date that statements are made and the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change. Investors are cautioned against attributing undue certainty to forward-looking statements. Reported by GlobeNewswire 51 minutes ago.
Proteas fast bowler, Dale Steyn, is revved up for a ‘competitive’ clash against Australia in the three-match ODI series starting in Perth on Sunday.
Reported by News24 22 minutes ago.
An American basketball player who flew into Brisbane with his French bulldog placed inside his hand luggage has run afoul of Australia's quarantine laws
Reported by News24 28 minutes ago.
The teams meet for their first international clash since the ill-tempered Test series wrapped up in Johannesburg in April with Australia's reputation in tatters and three of their players sent home in disgrace.
Reported by DNA 17 minutes ago.
An artificial intelligence (AI) programme used to recognise faces on Facebook can also identify galaxies in deep space, scientists said. The AI bot named ClaRAN scans images taken by radio telescopes, said researchers from the International Centre for Radio Astronomy Research (ICRAR) in Australia. Its job is to spot radio galaxies -- galaxies that emit powerful radio jets from supermassive black holes at their centres, according to the research published in the journal Monthly Notices of the Royal Astronomical Society.
Black holes are found at the centre of most, if not all, galaxies. "These supermassive black holes occasionally burp out jets that can be seen with a radio telescope," said Ivy Wong from The University of Western Australia node of the International Centre for Radio Astronomy Research (ICRAR). "Over time, the jets can stretch a long way from their host galaxies, making it difficult for traditional computer programmes to figure out where the galaxy is," said Wong.
ClaRAN grew out of an open source version of Microsoft and Facebook's object detection software. Wong said the programme was completely overhauled and trained to recognise galaxies instead of people. She said the upcoming EMU survey using the Australian Square Kilometre Array Pathfinder (ASKAP) telescope is expected to observe up to 70 million galaxies across the history of the universe.
Wong said traditional computer algorithms are able to correctly identify 90 per cent of the sources. "That still leaves 10 per cent, or seven million 'difficult' galaxies that have to be eyeballed by a human due to the complexity of their extended structures," Wong said. "If ClaRAN reduces the number of sources that require visual classification down to one per cent, this means more time for our citizen scientists to spend looking at new types of galaxies," she said.
A highly-accurate catalogue produced by Radio Galaxy Zoo volunteers was used to train ClaRAN how to spot where the jets originate. Chen Wu, also from ICRAR, said ClaRAN is an example of a new paradigm called 'programming 2.0'. "All you do is set up a huge neural network, give it a tonne of data, and let it figure out how to adjust its internal connections in order to generate the expected outcome," he said.
Monthly Notices of the Royal Astronomical Society
Royal Astronomical Society
Fri, 2 Nov 2018-05:12pm
Friday, 2 November 2018 - 5:12pm
Hide lead image:
'New artificial intelligence bot can recognise galaxies'
From Print Edition:
Highlights: Reported by DNA 5 minutes ago.
Kiana Smith, from Australia but living in Trinidad in the Caribbean, has a birthmark called a port wine stain, which is caused by a genetic default and cannot be cured, only treated.
Reported by MailOnline 5 minutes ago.
Matthew Hassan, Research Analyst at Westpac, points out that Australia’s September retail report was on the soft side as monthly sales rose 0.2%, a touch short of the consensus forecast of 0.3% but in line with Westpac's view.
“Annual sales growth held at 3.7%yr but sales have been tracking closer to a 3.3% annual pace over the last six months. The detail showed gains in the month concentrated in food categories (up 0.5% on a combined basis) with non food retail declining 0.2%mth.”
“Sales volumes for the quarter were more underdone, rising 0.2% vs consensus and Westpac forecasts of a 0.4% gain and with Q2's strong 1.2% gain revised back to a 1% increase.”
“The main surprise was around retail prices which rose 0.4% despite mostly subdued gains in the retail CPI components.”
“Overall, the soft Q3 result confirms some slowing in consumer demand in the quarter from the strong Q2. Vehicle sales also point to some softening although service sector indicators have held in more positive territory.”
Reported by FXstreet.com 23 hours ago.
This week’s Australia Letter explores the connection between international threats, journalism and technology.
Reported by NYTimes.com 23 hours ago.
Elliot Clarke, Research Analyst at Westpac, suggests that this week, inflation and the housing market have been in focus for Australia and inflation being an enduring disappointment for the market, with actual outcomes having come in below expectations quarter by quarter for close to two years.
“The September quarter continued this trend, with headline and the average of the core measures again sub-consensus at 0.4% (market 0.5%) and 0.3% (market 0.4%). More significant for policy, annual headline and core inflation again fell below the 2.0%yr lower bound of the RBA’s inflation range, now 1.9%yr and 1.7%yr.”
“Though petrol will remain inflationary in coming months, persistent weakness in housing costs will limit the net effect for headline inflation.”
“The soft housing inflation pulse is a consequence of declining house prices and rising supply (restricting rental growth). This week, the October CoreLogic house price data showed that this national decline in house prices is continuing.”
“Dwelling approvals data for September was also released this week. While a bounce was seen in the month, approvals are still down 14% over the year.”
“Given this trend decline in prices and approvals, it is unsurprising that housing credit growth continues to decelerate.” Reported by FXstreet.com 23 hours ago.
An American basketball player who flew into Brisbane with his French bulldog placed inside his hand luggage has run afoul of Australia's quarantine laws
Reported by Newsday 22 hours ago.
According to Bill Evans, Chief Economist at Westpac, the Reserve Bank Board of Australia will keep the cash rate on hold and maintain its upbeat growth and inflation forecasts despite rising risks.
“The Reserve Bank Board meets next week on November 6.”
“The Bank will also release the November Statement on Monetary Policy on November 9.”
“Of course the Governor will announce that there has been no change in the cash rate.”
“Today, markets are pricing only the probability of around 50% of one hike by end 2019 and a full 25bps is not priced-in until end 2020.” Reported by FXstreet.com 22 hours ago.
HANOI, Vietnam (AP) — HANOI, Vietnam (AP) — Vietnamese President Nguyen Phu Trong on Friday submitted a Pacific Rim trade pact to the National Assembly for approval, the government said. The Comprehensive and Progressive Agreement for Trans-Pacific Partnership will take effect at the year's end after Australia became the sixth nation to ratify it, earlier this week. President Donald Trump pulled out of the pact just days after taking office last year. The remaining 11 members account for more than 13 percent of the world's GDP. Addressing lawmakers, Trong said the pact reflects Vietnam's strong commitment to reform and comprehensive international integration.
Reported by SeattlePI.com 22 hours ago.
BANGKOK (AP) — Asian shares advanced Friday after President Donald Trump and his Chinese counterpart Xi Jinping spoke by phone and the Chinese state media reported progress in resolving trade tensions between their two countries. KEEPING SCORE: Hong Kong's Hang Seng index jumped 3.8 percent to 26,365.04 and the Shanghai Composite index added 2.7 percent to 2,676.48. Japan's Nikkei 225 index surged 2.6 percent to 22,243.66 while South Korea's Kospi climbed 3.5 percent to 2,096.00. The S&P ASX/200 in Australia erased early losses to end up 0.1 percent at 5,849.20 and the SET in Thailand rose 0.9 percent. Shares also rose in Taiwan, India and Southeast Asia. CHINA-US TRADE: U.S.
Reported by SeattlePI.com 20 hours ago.
Althea Group Holdings Ltd’s (ASX:AGH) wholly-owned subsidiary Althea Company Pty Ltd has been granted a cannabis manufacture licence by the Australian Government’s Office of Drug Control. The licence provides Althea authorisation to manufacture extracts and tinctures of cannabis and cannabis resin according to relevant manufacture permits. READ: Althea reaches 100 patients for medicinal cannabis products in five months Althea chief executive officer Josh Fegan said the company was excited to receive its manufacture licence. “Coupled with the existing medicinal cannabis licence, Althea can now proceed with the next phase of planning for our Victorian-based production facility. “Althea shareholders can look forward to a vertically-integrated, ‘seed-to-sale’, state of the art medicinal cannabis operation, comparable to that of our Canadian partner Aphria.” Partnership with Canadian producer Althea’s partner Aphria Inc (TSE:APH) is one of Canada’s lowest-cost producers and suppliers of medicinal cannabis. The Ontario-based producer favours the most natural growing conditions available and is committed to providing pharma-grade medical cannabis and quality patient care while balancing economics and returns to shareholders. Aphria chief executive officer Vic Neufeld noted the milestone its Australian partner had achieved in receiving its manufacture licence. He said: “This is another step towards ensuring Australian patients have access to high-quality medicinal cannabis.” Aphria holds a 25% interest in Althea. Aiming for 1,000 patients Fegan said the granting of the manufacture licence was further validation of Althea’s business model. He added: “Patients approved for Althea medicinal cannabis products have quickly surpassed the recent 100 patient milestone, with 127 patients now approved. “Similarly, the number of doctors prescribing Althea products has increased from 42 to 50 in the last two weeks – and we are just getting started. “Our aim is to reach 1,000 patients by this time next year and the comprehensive work we are doing educating mainstream doctors across Australia makes that a distinct possibility.” Five medicinal cannabis products available in Australia Althea was founded in 2017 and has through strategic supply and distribution partnerships started sale of five Althea-branded medicinal cannabis products in Australia. The Melbourne-based cannabis company’s focus on patient care underpins its business strategy and its innovative web-based platform and mobile application Althea Concierge is designed to educate and support patient access to medicinal cannabis.
Reported by Proactive Investors 20 hours ago.
Graham Morant, 69, was sentenced to 10 years in prison for persuading his wife Jennifer Morant to kill herself in 2014.
Reported by FOXNews.com 15 hours ago.
Hosted enterprise WMS applications add new level of operational efficiency by transferring the IT burden from customers to a world class hosting partner
DENVER (PRWEB) November 02, 2018
Cadre Technologies has partnered with Meridian IT Inc., a Meridian Group International Company, to make its warehouse management systems available as cloud-based applications. Meridian IT provides infrastructure as a service for Cadre’s Cadence WMS and Accuplus WMS to eliminate the need for in-house IT staffing and equipment.
Online IT provisioning simplifies the entire platform and ensures consistency, automated back-ups, network monitoring and scalable capacity. The platform allows customers to focus on operations and business instead of internally managing server capacity, platform software and network issues. It also makes expansion of computing capacity seamless so that Cadre customers can grow their business without physically adding new servers, licenses and IT staffing.
“Meridian IT’s secure facilities, highly trained staff and state-of-the-art network provides a stable environment to effectively manage their Cadre software solution," explained Daryl Grove, Cadre's Executive VP. “It provides secure data communications, redundant bandwidth and ongoing operational support. Our customers simply cannot do IT better on their own.”
Meridian’s 24/7 technical support, in combination with Cadre’s software support, greatly expands system availability and reliability. It also provides tailored configurations for each customer’s unique situation. It supports the Cadence WMS Microsoft Windows platform as well as the Accuplus Linux operating system. The hosted environment provides Cadre customers a significant amount of confidence and peace of mind.
About Cadre Technologies
Cadre Technologies is a leading innovator of software for fulfillment and logistics operations including warehouse management, transportation management and online collaboration. Products include Accuplus 3rd Party Logistics WMS; LogiView, SaaS based supply chain control tower; and Cadence Warehouse Management System. The company is based in Denver, Colorado with offices in Lenexa, Kansas and Baltimore, Maryland. Cadre is a FOG Software Group company, part of Constellation Software Inc. (TSX:CSU). For more information, visit http://www.cadretech.com.
About Meridian IT
Meridian IT Inc. is a leading information technology company. Clients leverage comprehensive hybrid IT solutions, technical expertise, and a broad range of deployment and management options. Meridian IT combines industry-relevant experience, with solution design skills, to drive innovation while achieving business outcomes. Learn more at http://www.meridianitinc.com
About Meridian Group International
Meridian Group International, privately owned and headquartered in Deerfield, IL is a highly-regarded professional organization with over 775 employees providing flexible equipment leasing across all asset types, new or refurbished, and leading global IT solutions, services, and support. Committed to strong customer relationships, Meridian Group has extensive knowledge and skills to help businesses innovate and grow while managing costs. Operating since 1979, in North America, Europe, Australia and Asia, discover more at http://www.onlinemeridian.com Reported by PRWeb 14 hours ago.
TransMachine Additive and The Barnes Group Advisors sign strategic collaboration agreement
WINSTON-SALEM, N.C. (PRWEB) November 02, 2018
The scope of the agreement includes The Barnes Group Advisors (TBGA) providing strategic leadership with Laura Ely as President of TransMachine Additive (TMA) and The Barnes Group Advisors providing TMA with technical support via the Technical Excellence Resource Model (TERM). The Technical Excellence Resource Model allows TMA to tap into TBGA technical expertise for application development without the overhead burdens of a large business.
”We are excited to support TMA’s growth via the TERM concept,” says John Barnes, Managing Director, The Barnes Group Advisors. “It is a great opportunity to leverage our diverse experience in additive manufacturing to reduce risk and accelerate time to profitability.”
The objective of the collaboration is to build on TMA’s mission to provide world class EBM additively manufactured products in an agile, cost-effective, and customer-focused environment.
“I’ve always had a vision to expand our high quality, precision manufacturing presence in the US,” says Barry Leonard, CEO, TransMachine Additive. “With our investment in EBM additive manufacturing and the industry leading business and technical expertise of The Barnes Group Advisors, that dream is rapidly becoming a reality.”
TMA is ready to support customer programs ranging from early application development to serial production. Full product solutions are available with project management including delivery of fully finished parts. TMA operates out of a 22,000 square foot ITAR registered production facility in Winston-Salem, North Carolina. They currently operate an Arcam Q20plus and Arcam A2X system. TMA plans to be AS9100 certified by early 2019.
To learn more about TransMachine Additive, please visit http://www.trans-machine.com/additive.
TransMachine Additive is a division of TransMachine Technologies (TMT). TMT is a Global Supplier of precision components to the Railroad, Mining, Automotive and OEMs. TMT offers high precision components through Additive Manufacturing, Casting, Precision Machining and Fabrication.
The Barnes Group Advisors is the largest independent additive manufacturing engineering consultancy. Headquartered in Pittsburgh, Pennsylvania, TBGA has presence in Australia, the United Kingdom, Austin, TX, Phoenix, AZ, Youngstown, OH, St. Louis, MO and State College, PA. TBGA helps companies work through their AM adoption strategy via strategy, design, leadership, training, metallurgy, and economics, and is comprised of seasoned specialists with well over 100 years of experience in additive manufacturing. Reported by PRWeb 11 hours ago.
Reported by FXstreet.com 5 hours ago.
In a new book by journalist Mark Urban, which tells the story of Mr Skripal's life, it is detailed how British government officials were considering moving the pair to a 'Five Eyes' country such as Australia.
Reported by MailOnline 2 hours ago.